The Opioid Rotation Ratio of Hydrocodone to Strong Opioids in Cancer Patients

Oncologist - United States
doi 10.1634/theoncologist.2014-0130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids Among 2443 Terminal Cancer Patients Receiving Opioids

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2017English

Opioid Rotation With Extended-Release Opioids: Where Should We Begin?

International Journal of General Medicine
Medicine
2011English

A Brief Information Sheet on Opioid Effects Improves Quality of Life in Cancer Patients on Opioids

The Internet Journal of Pain, Symptom Control and Palliative Care
2003English

Initiation of Strong Prescription Opioids in Australia: Cohort Characteristics and Factors Associated With the Type of Opioid Initiated

British Journal of Clinical Pharmacology
Pharmacology
2016English

Factors Affecting Opioid Treatment in Cancer Patients

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2018English

Intravenous Oxycodone, Hydrocodone, and Morphine in Recreational Opioid Users: Abuse Potential and Relative Potencies

Psychopharmacology
Pharmacology
2010English

Evaluation of the Optimal Positioning of Subcutaneous Butterfly When Administering Injectable Opioids in Cancer Patients

Medicine and Pharmacy Reports
Medicine
2016English

The Role of Opioid Analgesics in the Treatment of Pain in Cancer Patients

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy